Introduction
N-arachidonoylethanolamine (anandamide) is referred to as the first 'endocannabinoid' described, and anandamide signaling has been reported to be an inhibitor of axon regeneration. Anandamide acts primarily on cannabinoid receptor type 1 (CB 1 ) [1] , cannabinoid receptor type 2 (CB 2 ) [2] , and ionotropic receptors, including the transient receptor potential (TRP) vanilloid type 1 (TRPV1) [3] [4] [5] , TRP ankyrin type 1 (TRPA1) and TRP melastatin type 8 (TRPM8) channels [6] . Anandamide can also directly modulate various other ion channels [5, [7] [8] [9] [10] . CB 1 and CB 2 are members of the subfamily of G-protein-coupled receptors and predominantly couple to Gi/o [1, 11] to produce multiple cellular effects, such as the inhibition of adenylate cyclase and of voltage-gated calcium channels [12] [13] [14] , regulation of potassium currents [15] [16] [17] , and increase of Ca 2+ influx via G s [18] and G q [19] . TRPV1 is a polymodal sensor of noxious stimuli including heat, hydrogen ions and capsaicin [20] . CB 1 [21] and TRPV1, but not CB 2 [21] are expressed in presynaptic primary neurons such as those in the trigeminal ganglion. CB 1 is localized to presynaptic nerve terminals [22] and contributes to the regulation of neuronal excitability and neurotransmitter release by modulating Ca 2+ signals. TRPV1 activation causes Ca 2+ to enter into the cell and promotes neurotransmitter release. Studies have demonstrated that anandamide can activate TRPV1 by binding to cytosolic sites [23] . The co-expression and close distribution of CB 1 and TRPV1 in primary sensory neurons [24] [25] [26] [27] allows cross-talk between these two receptors, which further complicates the role of anandamide in nociception and antinociception. The present study will determine which receptor contributes to the effect of low and high concentrations of anandamide in small trigeminal ganglion neurons.
It is a widely accepted general hypothesis that endocannabinoids inhibit neurotransmitter release from primary afferent neurons by reducing Ca 2+ influx via an inhibitory action on high voltage-gated Ca 2+ channels. This hypothesis is supported by evidence that CB 1 activation by anandamide
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on primary nociceptive neurons causes antinociception by reducing high voltage-activated Ca 2+ channel activity [12] [13] [14] and Ca 2+ influx [28] , thus inhibiting neurotransmission. In contrast, some studies suggest that cannabinoids can promote Ca 2+ influx and hence increase neurotransmitter release in vitro [19, 25, [29] [30] [31] . How endocannabinoids may cause such opposing effects in intracellular Ca 2+ concentration and neuron excitability is unclear. High voltage-gated calcium channels and ligand-gated channels, two important contributors to intracellular Ca 2+ concentration, will also be investigated. The present study tests the above hypothesis by determining the effect of anandamide on high voltage-activated Ba 2+ currents (I HVA ), Ca 2+ influx and intracellular Ca 2+ concentration, as well as the underlying mechanisms, in small trigeminal ganglion neurons.
Results

Anandamide-evoked inward currents
Whole-cell patch-clamp recordings were carried out in rat trigeminal ganglion neurons with bath perfusion of 0.1, 0.3, 1, 3, 10, 30 and 100 µmol/L anandamide at a range of holding potentials from −60 mV to +60 mV ( Figure 1 ). Reversal potentials were around 0 mV. Anandamide-evoked inward and outward currents at holding potentials of −60 mV and +60 mV, respectively, were dose-dependent ( Figure 2 ).
Inhibition of I HVA by anandamide
Bath application of anandamide (0.001, 0.01, 0.1, 1, 10, 30 µmol/L) inhibited I HVA in a concentration-dependent manner, by 4.62 ± 0.88%, 6.24 ± 2.57%, 18.17 ± 0.99%, 31.30 ± 3.21%, 64.73 ± 1.95% and 55.19 ± 2.06%, respectively (n = 4-11). The effect of anandamide was partially reversed after washout. The Hill equation was applied to the dose-response curve and revealed that the half-maximal inhibitory concentration (IC 50 ) of anandamide was 0.92 µmol/L. To confirm whether other CB 1 agonists mimicked the inhibition of anandamide, we tested the effect of WIN 55,212-2 (10 µmol/L) on I HVA . The inhibition of I HVA by 10 µmol/L WIN 55,212-2 was 55.78 ± 6.07%. Anandamide at 1 µmol/L reduced current amplitudes ( Figure 3A , B) but did not cause a significant shift of the activation curve ( Figure 3C ). However, a hyperpolarization shift of almost 14 mV (n = 8; P < 0.05) was ob- [21] . Inhibition of I HVA by capsaicin As described above, inhibition of I HVA by high-concentration anandamide was reversed by the TRPV1 antagonist capsazepine, suggesting that TRPV1 is involved in this effect. We further tested whether I HVA could be directly inhibited by the TRPV1 agonist, capsaicin. Capsaicin and capsazepine were applied by bath perfusion. I HVA was reversibly inhibited by capsaicin in a dose-dependent manner ( Figure 5 ). Similar to the effect observed with high-concentration anandamide, the decrease in I HVA by capsaicin was reversed by 10 µmol/L capsazepine. In addition, I HVA was not inhibited by 10 µmol/L capsazepine ( Figure 6 ).
Characterization of signal transduction pathways mediating the inhibition of I HVA via cannabinoid type-1 receptor activation by low-concentration anandamide Three important signal transduction systems were examined using specific agonists and antagonists to test whether these Cannabinoid / vanilloid type-1 receptor involvement in the mechanism underlying increased intracellular Ca 2+ concentration evoked by anandamide Because AM630 had no effect on the inhibition of anandamide on I HVA , in the present test only AM251 and capsazepine were used, to determine whether they would affect the increase of anandamide on the intracellular Ca 2+ concentration, using calcium imaging. The 1 µmol/L anandamide-induced rise in intracellular Ca 2+ concentration was abolished by co-application with 10 µmol/L AM251 ( Figure 8C ), while lower doses of AM251 (1 and 3 µmol/L) facilitated the in- Figure 8C ). This suggests that co-incubation with 1 µmol/L anandamide and low-dose AM251 facilitates intracellular Ca 2+ influx via TRPV1 while at the same time inhibiting it via CB 1 receptors.
Similar to the effect of 10 µmol/L anandamide observed on I HVA , the increase in intracellular Ca 2+ concentration was also blocked by both AM251 and capsazepine ( Figure 8C ), indicating that different receptors participate in the responses of intracellular Ca 2+ concentration to low and high concentrations of anandamide in rat trigeminal ganglion neurons.
Signaling pathways mediating the increase in intracellular Ca
2+ concentration after cannabinoid receptor activation by low-concentration anandamide Calcium imaging was used to evaluate the possible contribution of cAMP-dependent protein kinase, protein kinase C, and cGMP-dependent protein kinase systems to the observed effect on intracellular Ca 2+ concentration after CB1
activation. The effects of 1 µmol/L anandamide on intracellular Ca 2+ concentrations in trigeminal ganglion neurons pre-treated with KT5720 (an inhibitor of cAMP-dependent protein kinase), staurosporine (an inhibitor of protein kinase C) and KT5823 (an inhibitor of cGMP-dependent protein kinase) were investigated. Figure 8D showed that staurosporine (10 µmol/L for 15 minutes) had no effect on the rise in intracellular Ca 2+ concentration after anandamide application (n = 13, P > 0.05). Pretreatment with KT5720 (10 µmol/L for 10 minutes) and KT5823 (10 µmol/L for 10 minutes) markedly attenuated the response of 1 µmol/L anandamide ( Figure  8D ). These data suggest that the cAMP-dependent protein kinase and cGMP-dependent protein kinase systems, but not the protein kinase C system, are involved in the increase in intracellular Ca 2+ concentration with 1 µmol/L anandamide.
Discussion
It is well established that presynaptic CB 1 receptor activation has an inhibitory role on high voltage-activated Ca 2+ channels, resulting in a decrease in Ca 2+ influx and an inhibition of neurotransmitter release. In contrast, results from the present study show that anandamide causes a dose-dependent elevation of intracellular Ca 2+ concentration, triggered by anandamide-evoked currents, but not modulation of high voltage-activated Ca 2+ channels by anandamide. Furthermore, anandamide-induced inhibition of the high voltage-activated Ca 2+ channels and the increase in the intracellular Ca 2+ concentration are demonstrated to be two separate events differing in signal transduction pathways but having similar effects via the same receptors. Thus, our data suggest that anandamide, as an endocannabinoid, might exert an excitatory effect by increasing intracellular Ca 2+ concentration, triggered by anandamide-evoked currents.
It has been well documented that the endocannabinoid anandamide, and its synthetic analogue methanandamide, have dual effects. At low concentrations, anandamide selectively activates CB 1 receptors, while at high concentrations it activates excitatory TRPV1 receptors [24] . In pre-contracted strips of rat hepatic artery, rat small mesenteric artery and guinea-pig basilar artery, vasorelaxation induced by high-concentration anandamide is antagonized by the TRPV1 antagonist capsazepine, but not by the CB 1 receptor antagonist SR141716 (0.3 µmol/L) [4] . Further evidence indicates that anandamide not only acts on transfected TRPV1 receptors to produce membrane currents and increase the intracellular Ca 2+ concentration [4, 32] , but also acts on naturally-expressed TRPV1 receptors in neonatal rat dorsal root ganglia to produce membrane currents [33] . Here, we present strong evidence that anandamide selectively activates the CB 1 receptor at low concentrations in small trigeminal ganglion neurons. At high concentrations, anandamide activates both CB 1 and TRPV1 receptors, inhibiting I HVA . To confirm that high-concentration anandamide inhibited I HVA via TRPV1 receptor activation, we compared the effects of high-concentration anandamide and the TRPV1 agonist capsaicin. We found that the inhibition induced by high-concentration anandamide and by capsaicin shared similar characteristics. First, both inhibited I HVA in a dose-dependent manner and were reversed by the TRPV1 receptor antagonist capsazepine. Second, like capsaicin, high-concentration anandamide induced inward currents in cultured trigeminal ganglion neurons. Similar to capsaicin-induced inward current, the reversal potential of anandamide-induced current was also around 0 mV. Anandamide had different effects at low and high concentration via the activation of different receptors. By comparing the contribution of CB 1 and TRPV1 activation on anandamide-induced increases in intracellular Ca 2+ concentration, we conclude that anandamide-induced inhibition of high voltage-activated Ca 2+ channels and an increase in intracellular Ca 2+ concentration have the same dual effects as activation of the receptor pathway.
Inhibition of high voltage-activated Ca 2+ channels and modulation of Ca 2+ influx are important for neuronal activity and neurotransmitter release induced by endocannabinoids. However, evidence also suggests that cannabinoids can couple to G s [18] and G q [19] and activate TRPV1 receptors to increase Ca 2+ influx. In addition, the response of cannabinoids on intracellular Ca 2+ concentration differs across cell types [34] . To elucidate the complex mechanisms underlying the intracellular Ca 2+ response, we further tested the effect of anandamide on intracellular Ca 2+ concentration. We found that anandamide increased intracellular Ca 2+ and simultaneously inhibited I HVA in the same population of trigeminal ganglion neurons, providing strong evidence that an increase in the intracellular Ca 2+ concentration is not due to I HVA . We found that anandamide had dual effects on the inhibition of I HVA and elevation of intracellular Ca 2+ concentration. However, by comparing the contribution of second messenger system, we found that cAMP-and cGMP-dependent protein kinase antagonists both reversed the anandamide-induced increase in intracellular calcium concentration and I HVA inhibition. Application of a protein kinase C antagonist reversed the inhibition of I HVA but the anandamide-induced increase in intracellular Ca 2+ concentration was not blocked. From this, we can conclude that the increase in intracellular Ca 2+ concentration and the I HVA inhibition observed with anandamide are separate processes that share the same receptors but differ in intracellular signal transduction pathways. CB 1 receptor activation by endocannabinoids has been mostly reported to cause depression of neuronal excitability and neurotransmitter release in presynaptic primary neurons [10, 13, 25, 28, [35] [36] . Accumulating evidence indicates that cannabinoids may contribute to the potentiation of neurotransmission. Endocannabinoid release potentiates synaptic transmission via CB 1 receptor activation and dopamine release in the goldfish Mauthner cell [37] . Moreover, endocannabinoids may potentiate hippocampal synaptic transmission via astrocytic CB 1 activation [30] . In the suprachiasmatic nucleus, CB 1 receptor activation can increase excitability of circadian clock neurons [38] . It is widely accepted that CB 1 receptor activation suppresses neurotransmission by inhibiting high voltage-activated Ca 2+ channels, and decreases Ca 2+ influx. In contrast to this general hypothesis, we found that endocannabinoids caused elevation of the intracellular Ca 2+ concentration in trigeminal ganglion neurons, which was triggered by endocannabinoid-evoked inward current around the resting membrane potential (−60 mV). Furthermore, endocannabinoid-induced increase in intracellular Ca 2+ concentration and decrease of high voltage-activated Ca 2+ channels were two independent events, which had the same dual effects via sim- 
Materials and Methods
Design A cytological in vitro study. [39] .
Time and setting
Methods
Cell dissociation
Trigeminal ganglion neurons from Sprague-Dawley rats were cultured as described previously [40] . Briefly, trigeminal ganglia were dissected aseptically and washed with cold for 20-40 minutes at 37°C. Individual cells were dissociated by triturating them through a fire-polished glass pipette, followed by incubating with 10 µg/mL DNase I (type lV) in F12 medium (Life Technologies, Gaithersburg, MD, USA) for 10 minutes at 37°C, before centrifuging for 5 minutes at 1,000 r/min. After centrifuging three times, the cells were cultured in F12 supplemented with 10% fetal bovine serum. The cells were planted on poly-D-lysine pre-coated glass coverslips (15 mm diameter) and cultured no more than 12 hours at 37°C in a water saturated atmosphere with 5% CO 2 .
Patch-clamp recording
The cells were placed in a recording chamber mounted on an inverted microscope (Leica Inc., Solms, Germany) and perfused with extracellular solution at room temperature (21-22°C). Whole-cell patch-clamp experiments were carried out using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA, USA) and the output was digitized with a Digidata 1332A converter (Axon Instruments) and program pCLAMP 9.02 (Axon Instruments). Data were acquired at a sampling rate of 2 KHz. Cell membrane capacitance and series resistance were measured and compensated (> 90%). The volume of the recording chamber was about 1 mL and the local superfusion rate was 1 mL/min.
Calcium imaging
Drug-induced changes of high voltage-activated Ca 2+ channels were measured using a confocal laser scanning imaging system (Fluoview FV500, Olympus, Tokyo, Japan). The trigeminal ganglion cells on glass cover slips were loaded with 
Data analysis
The data were analyzed using pCLAMP 9.02 (Axon Instruments) and Sigmaplot 11.0 software (Systat Software Inc., San Jose, CA, USA). The amplitude of I HVA was calculated as the peak current. Voltage-dependent activation for the study of changes on I HVA was measured by a series of depolarized pulses (450 ms) from −50 mV to +40 mV, stepping by 10 mV with interval time of 5 seconds, at a holding potential of −80 mV. We fitted a Boltzmann function to the voltage-dependent activation curves, that is G /G max =1/[1+exp (V 0.5 -V m )/k], where G max is the maximum conductance, V 0.5 is the membrane potential at which 50% of activation was observed, and k is the slope of the function. Voltage-dependent inactivation was measured by a two pulse protocol in which the precondition pulses (3 seconds) ranged from −80 to +20 in 10 mV increments; following test pulse (200 millsecords) was +10 mV with an internal time of 6 seconds. The Boltzmann function was also fitted to the h-infinity curve, that is, I/ I max =1/[1+exp(V 0.5 -V m )/k], where V 0.5 is the membrane potential at which 50% of inactivation was observed, and k is the slope of the function. The dose-response curve was fitted by the Hill equation, in which, I peak =I peakmax /[1+(IC 50 /C) n ], with IC 50 as the concentration producing 50% inhibition and n as the Hill coefficient.
Statistical analysis
Data were presented as mean ± SEM. For all experiments, data were examined for Gaussian distribution first, and then analyzed for statistical significance using the paired or unpaired t-test and one-way analysis of variance by using Sigma plot 11.0 software (Systat Software Inc.). A value of P < 0.05 was considered statistically significant. Liu LJ 
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